Astrana Health (NASDAQ:ASTH) Price Target Increased to $48.00 by Analysts at Stifel Nicolaus

Astrana Health (NASDAQ:ASTH) had its price objective hoisted by Stifel Nicolaus from $45.00 to $48.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock.

ASTH has been the subject of several other research reports. Robert W. Baird initiated coverage on shares of Astrana Health in a report on Thursday, May 30th. They issued an outperform rating and a $54.00 price target for the company. Baird R W upgraded shares of Astrana Health to a strong-buy rating in a research note on Thursday, May 30th. Finally, Truist Financial boosted their price objective on shares of Astrana Health from $41.00 to $44.00 and gave the stock a hold rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Buy and an average price target of $49.00.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $40.77 on Thursday. Astrana Health has a one year low of $28.86 and a one year high of $45.71. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.52 and a current ratio of 1.52. The company has a market cap of $2.28 billion, a price-to-earnings ratio of 30.89, a P/E/G ratio of 1.41 and a beta of 1.12. The firm has a 50-day simple moving average of $39.42.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a net margin of 4.29% and a return on equity of 10.22%. The business had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. During the same quarter in the prior year, the firm posted $0.42 EPS. The company’s revenue for the quarter was up 19.9% compared to the same quarter last year. On average, research analysts predict that Astrana Health will post 1.41 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.